ArticleDrug discovery today. Therapeutic strategies2008
Cyclooxygenase products and atherosclerosis.
Article in Drug discovery today. Therapeutic strategies, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- The Perspectives of Platelet Proteomics in Health and Disease.Biomedicines · 2024Review
- The Evolving Role of Dendritic Cells in Atherosclerosis.International journal of molecular sciences · 2024Review
- Human Coronary Artery Endothelial Cell Response toMicroorganisms · 2024Article
- Influence of variability in the cyclooxygenase pathway on cardiovascular outcomes of nephrosclerosis patients.Scientific reports · 2023Article
- Molecular docking studies and biological evaluation of isoxazole-carboxamide derivatives as COX inhibitors and antimicrobial agents.3 Biotech · 2022Article
- Lipid metabolism patterns and relevant clinical and molecular features of coronary artery disease patients: an integrated bioinformatic analysis.Lipids in health and disease · 2022Article
- Levels of Cyclooxygenase 2, Interleukin-6, and Tumour Necrosis Factor-Oxidative medicine and cellular longevity · 2021Article
- Exploring the Mechanism of Gyejibokryeong-hwan against Atherosclerosis Using Network Pharmacology and Molecular Docking.Plants (Basel, Switzerland) · 2020Article
- Inflammation-induced atherosclerosis as a target for prevention of cardiovascular diseases from early life.The open cardiovascular medicine journal · 2010Article
- Macrophage EP4 deficiency increases apoptosis and suppresses early atherosclerosis.Cell metabolism · 2008Article
- Inflammatory Mediators in Xanthelasma Palpebrarum: Histopathologic and Immunohistochemical Study.Ophthalmic plastic and reconstructive surgeryArticle
- Role of endothelium-dependent hyperpolarisation and prostacyclin in diabetes.The Malaysian journal of medical sciences : MJMSArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.